Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 16–16 | Cite as

Afatinib

Drug resistance: case report
Case report
  • 16 Downloads

Reference

  1. Nasu S, et al. Osimertinib treatment was unsuccessful for lung adenocarcinoma with G719S, S768I, and T790M mutations. Internal Medicine 57: 3643-3645, No. 24, 2018. Available from: URL: http://doi.org/10.2169/internalmedicine.0923-18 -JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations